Collector
Giriş Yap
AstraZeneca's GLP-1 Pill Heads To Late-Stage Trials | Collector
AstraZeneca's GLP-1 Pill Heads To Late-Stage Trials

AstraZeneca's GLP-1 Pill Heads To Late-Stage Trials

AstraZeneca advances oral GLP-1 elecoglipron to Phase 3 following strong weight loss & diabetes data at ADA 2026. Get the trial details. Importance Rank: 1 read more

Go to News Site